¼¼°èÀÇ Àν¶¸° Ææ ´Ïµé ½ÃÀå
Insulin Pen Needles
»óǰÄÚµå : 1655518
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 193 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,130,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,390,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Àν¶¸° Ææ ´Ïµé ½ÃÀåÀº 2030³â±îÁö 42¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 29¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ Àν¶¸° Ææ ´Ïµé ½ÃÀåÀº 2024-2030³â¿¡ CAGR 6.7%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 42¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀΠǥÁØ Àν¶¸° Ææ ´ÏµéÀº CAGR 6.3%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 27¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾ÈÀü ¼³°è Àν¶¸° Ææ ´Ïµé ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 7.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 7¾ï 4,410¸¸ ´Þ·¯, Áß±¹Àº CAGR 9.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Àν¶¸° Ææ ´Ïµé ½ÃÀåÀº 2024³â¿¡ 7¾ï 4,410¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 9.8%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â ¿¹Ãø ½ÃÀå ±Ô¸ð 9¾ï 9,110¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.5%¿Í 6.0%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Àν¶¸° Ææ ´Ïµé ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Àν¶¸° Ææ ´ÏµéÀÌ ´ç´¢º´ °ü¸®¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

Àν¶¸° Ææ ´ÏµéÀº Ç÷´çÀ» °ü¸®Çϱâ À§ÇØ ¸ÅÀÏ Àν¶¸° Åõ¿©¿¡ ÀÇÁ¸ÇÏ´Â ´ç´¢º´ ȯÀÚ¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. Àν¶¸° Ææ¿ëÀ¸·Î ¼³°èµÈ ÀÌ ¹Ù´ÃÀº Àν¶¸°À» Æí¸®Çϰí Á¤È®ÇÏ°Ô Åõ¿©ÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ» Á¦°øÇÏ¿© Ä¡·á °èȹ Áؼö¸¦ µ½½À´Ï´Ù. ´ç´¢º´ À¯º´·üÀÌ ¼±Áø±¹°ú ½ÅÈï °æÁ¦±¹À» Áß½ÉÀ¸·Î Àü ¼¼°è¿¡¼­ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó È¿À²ÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î Àν¶¸° Àü´Þ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àν¶¸° ÆæÀÇ ¹Ù´ÃÀº ±âÁ¸ ÁÖ»ç±âº¸´Ù ´ú ħ½ÀÀûÀ̰í ÈÞ´ë°¡ °¡´ÉÇÑ ´ë¾ÈÀ» Á¦°øÇÔÀ¸·Î½á ´Ù¾çÇÑ È¯Àڵ鿡°Ô ´ç´¢º´ °ü¸®¸¦ º¸´Ù ½±°í Ä£¼÷ÇÏ°Ô ¸¸µé¾î ÁÝ´Ï´Ù.

±â¼ú Çõ½ÅÀº ¾î¶»°Ô Ææ ¹Ù´ÃÀÇ »ç¿ë ÆíÀǼº°ú ¾ÈÀü¼ºÀ» Çâ»ó½Ã۴°¡?

±â¼úÀÇ ¹ßÀüÀº Àν¶¸° Ææ ´ÏµéÀÇ ¾ÈÀü¼º, Æí¾ÈÇÔ ¹× »ç¿ë ÆíÀǼºÀ» Å©°Ô Çâ»ó ½ÃÄ×½À´Ï´Ù. ÃֽŠÁÖ»ç¹Ù´ÃÀº Ãʹ̼¼ ¼³°è·Î ÁÖ»ç ÅëÁõÀ» ÁÙÀ̰í ȯÀÚÀÇ Æí¾ÈÇÔÀ» ³ôÀÔ´Ï´Ù. ½Ç¼ö·Î ¹Ù´Ã¿¡ Âñ¸®´Â »ç°í¸¦ ¹æÁöÇϱâ À§ÇØ ¹Ù´Ã ÀÚµ¿ ¼öÃà ¹× ÆÁ ½¯µå¿Í °°Àº ¾ÈÀü ±â´ÉÀÌ ³»ÀåµÇ¾î ÀÖÀ¸¸ç, ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡°Ô ÀÌÀÍÀÌ µË´Ï´Ù. ¶ÇÇÑ ¹Ù´ÃÀÇ ÄÚÆÃ°ú º£º§ µðÀÚÀÎ Çõ½ÅÀ» ÅëÇØ ÁÖ»ç½Ã Á¶Á÷ ¼Õ»óÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â´É °­È­·Î Àν¶¸° ÆæÀÇ ¹Ù´ÃÀº ƯÈ÷ Àν¶¸° Ä¡·á¸¦ óÀ½ ¹Þ´Â ȯÀÚ³ª ÁÖ»ç ¹Ù´Ã¿¡ ´ëÇÑ µÎ·Á¿òÀÌ Àִ ȯÀڵ鿡°Ô ´õ¿í ¸Å·ÂÀûÀÌ°í ´Ù·ç±â ½¬¿î ¹Ù´ÃÀÌ µÇ¾ú½À´Ï´Ù.

±ÔÁ¦ ±âÁØÀº ½ÃÀå¿¡¼­ ¾î¶² ¿ªÇÒÀ» Çϴ°¡?

¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀº Àν¶¸° Ææ ´ÏµéÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇØ µðÀÚÀÎ, Àç·á ¹× Á¦Á¶ °øÁ¤¿¡ ¿µÇâÀ» ¹ÌÄ¡¸ç, FDA ¹× EMA¿Í °°Àº ±ÔÁ¦±â°üÀº ¾ö°ÝÇÑ ÁöħÀ» ÁؼöÇϰí ÀÌ·¯ÇÑ ÀÇ·á±â±â°¡ ȯÀÚ »ç¿ëÀ» À§ÇÑ °íǰÁú ±âÁØÀ» ÃæÁ·Çϵµ·Ï ¿ä±¸ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±âÁØÀº ȯÀÚ¿Í ÀÇ·áÁø¿¡°Ô Á¦Ç°ÀÇ ½Å·Ú¼º°ú ¾ÈÀü¼º¿¡ ´ëÇÑ È®½ÅÀ» Áֱ⠶§¹®¿¡ ƯÈ÷ Áß¿äÇÕ´Ï´Ù. ±ÔÁ¦ Áؼö´Â ¶ÇÇÑ Á¦Á¶¾÷ü°¡ ¾ÈÀüÇÑ ¸Å°³ º¯¼ö ³»¿¡¼­ ±â¼ú Çõ½ÅÀ» ÃËÁøÇÏ¿© ´õ ¾ÈÀüÇϰí, ´õ Æí¾ÈÇϰí, ´õ »ç¿ëÇϱ⠽¬¿î ¹Ù´ÃÀÇ °³¹ßÀ» ÃËÁøÇÏ°í ½ÃÀå °³Ã´¿¡ ±â¿©ÇÕ´Ï´Ù.

Àν¶¸° Ææ ´Ïµé ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù

Àν¶¸° Ææ ´Ïµé ½ÃÀåÀÇ ¼ºÀåÀº ´ç´¢º´ À¯º´·ü Áõ°¡, Àúħ½ÀÀû Àν¶¸° Àü´Þ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä, ¹Ù´Ã µðÀÚÀÎÀÇ Çõ½Å µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ´ç´¢º´ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ƯÈ÷ µµ½Ã Áö¿ª°ú °í·ÉÈ­ Àα¸ Áý´Ü¿¡¼­ È¿À²ÀûÀÌ°í »ç¿ëÇÏ±â Æí¸®ÇÑ Àν¶¸° Àü´Þ ¹æ¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Ãʹ̼¼ ÁÖ»ç¹Ù´Ã µðÀÚÀÎ, ¾ÈÀü ±â´É µî ±â¼ú °³¼±À¸·Î ȯÀÚ °æÇè°ú ¼øÀÀµµ°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¾ÈÀü°ú ǰÁúÀ» º¸ÀåÇÏ´Â ±ÔÁ¦ ±âÁصµ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, Àü ¼¼°è¿¡¼­ °íǰÁúÀÇ ½Å·ÚÇÒ ¼ö ÀÖ´Â Àν¶¸° Ææ ´ÏµéÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¿ëµµ(Á¦1Çü ´ç´¢º´, Á¦2Çü ´ç´¢º´) ; Á¦Ç° À¯Çü(Ç¥ÁØ Àν¶¸° Ææ ´Ïµé, ¾ÈÀü ¼³°è Àν¶¸° Ææ ´Ïµé)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 43»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Insulin Pen Needles Market to Reach US$4.2 Billion by 2030

The global market for Insulin Pen Needles estimated at US$2.9 Billion in the year 2024, is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Standard Insulin Pen Needles, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Safety-Engineered Insulin Pen Needles segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$744.1 Million While China is Forecast to Grow at 9.8% CAGR

The Insulin Pen Needles market in the U.S. is estimated at US$744.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$991.1 Million by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Insulin Pen Needles Market - Key Trends & Drivers Summarized

Why Are Insulin Pen Needles Crucial in Diabetes Management?

Insulin pen needles are essential for diabetes patients who rely on daily insulin administration to manage their blood sugar levels. These needles, designed for use with insulin pens, offer a convenient and precise method for insulin delivery, supporting adherence to treatment regimens. As the prevalence of diabetes continues to rise globally, especially in developed and emerging economies, demand for efficient and user-friendly insulin delivery devices has increased. Insulin pen needles provide a less invasive and more portable alternative to traditional syringes, making diabetes management easier and more accessible for a wide range of patients.

How Are Innovations Enhancing Pen Needle Usability and Safety?

Technological advancements are significantly improving the safety, comfort, and usability of insulin pen needles. Modern needles feature ultra-thin designs, reducing injection pain and increasing patient comfort, a critical factor in maintaining consistent treatment adherence. Safety features such as automatic needle retraction and shielded tips are being incorporated to prevent accidental needlesticks, benefiting both patients and healthcare providers. Additionally, innovations in needle coating and bevel designs help minimize tissue damage during injections. These enhancements are making insulin pen needles more appealing and manageable, especially for individuals new to insulin therapy or those with needle anxiety.

What Role Do Regulatory Standards Play in the Market?

Strict regulatory standards ensure the safety and efficacy of insulin pen needles, impacting their design, materials, and production processes. Regulatory bodies like the FDA and EMA require compliance with stringent guidelines, ensuring that these medical devices meet high-quality standards for patient use. These standards are particularly important as they reassure patients and healthcare providers of the reliability and safety of the products. Regulatory compliance also encourages manufacturers to innovate within safe parameters, driving the development of needles that are safer, more comfortable, and easier to use, contributing to market growth.

The Growth in the Insulin Pen Needles Market Is Driven by Several Factors

The growth in the insulin pen needles market is driven by several factors, including the increasing prevalence of diabetes, demand for minimally invasive insulin delivery solutions, and innovations in needle design. As diabetes rates climb, particularly in urbanized and aging populations, the need for efficient and user-friendly insulin delivery methods is expanding. Technological improvements, such as ultra-thin needle designs and safety features, are enhancing patient experience and compliance. Regulatory standards that ensure safety and quality are also influencing the market, encouraging the adoption of high-quality, reliable insulin pen needles globally.

SCOPE OF STUDY:

The report analyzes the Insulin Pen Needles market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Type I Diabetes, Type II Diabetes); Product Type (Standard Insulin Pen Needles, Safety-Engineered Insulin Pen Needles)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â